170 related articles for article (PubMed ID: 17634465)
1. Atherothrombosis--wave goodbye to combined anticoagulation and antiplatelet therapy?
Mohler ER
N Engl J Med; 2007 Jul; 357(3):293-6. PubMed ID: 17634465
[No Abstract] [Full Text] [Related]
2. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
Tangelder MJ; van Hattum ES
Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897
[No Abstract] [Full Text] [Related]
4. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
Mohler ER
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
[TBL] [Abstract][Full Text] [Related]
5. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
Faxon DP
Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
[TBL] [Abstract][Full Text] [Related]
6. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
[No Abstract] [Full Text] [Related]
7. Bleeding risk of combined oral anticoagulant and antiplatelet therapy in cardiovascular disease.
Verheugt FW
J Cardiovasc Risk; 1996 Apr; 3(2):229-32. PubMed ID: 8836868
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
Poredos P; Jezovnik MK
Int Angiol; 2010 Feb; 29(1):20-6. PubMed ID: 20224527
[TBL] [Abstract][Full Text] [Related]
9. Challenges of antiplatelet therapy in patients who require anticoagulation.
Henkel DM; Holmes DR
J Invasive Cardiol; 2009 Apr; 21(4):186-9. PubMed ID: 19342758
[No Abstract] [Full Text] [Related]
10. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy in peripheral arterial disease.
Lipsitz EC; Kim S
Clin Geriatr Med; 2006 Feb; 22(1):183-98, x. PubMed ID: 16377474
[TBL] [Abstract][Full Text] [Related]
12. [Risk factor control in peripheral arterial disease can be improved. Registry study of secondary prophylactic drug therapy].
Alhadad A; Wiktorsson C; Lindblad B; Gottsäter A
Lakartidningen; 2010 Sep 29-Oct 5; 107(39):2322-5. PubMed ID: 20973248
[No Abstract] [Full Text] [Related]
13. Cardiovascular risk associated with interruption of antiplatelet and oral anticoagulation therapy.
Ferreira JS; Gil VM
Rev Port Cardiol; 2009; 28(7-8):845-58. PubMed ID: 19894663
[TBL] [Abstract][Full Text] [Related]
14. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Apostolakis S; Shantsila E; Lip GY; Lane DA
Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
[No Abstract] [Full Text] [Related]
15. Dual antiplatelet therapy in the secondary prevention of atherothrombosis: need for new therapeutic approaches.
Sabatier B; Trinquart L; Emmerich J
Arch Cardiovasc Dis; 2010 Oct; 103(10):497-501. PubMed ID: 21130962
[No Abstract] [Full Text] [Related]
16. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
[TBL] [Abstract][Full Text] [Related]
17. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
WAVE Investigators
Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
[TBL] [Abstract][Full Text] [Related]
18. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
Chapman MJ
Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
[TBL] [Abstract][Full Text] [Related]
19. Commentary on "Antiplatelet therapy for vascular interventions".
Srivastava SD
Perspect Vasc Surg Endovasc Ther; 2008 Mar; 20(1):36-7. PubMed ID: 18403468
[No Abstract] [Full Text] [Related]
20. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
